Top-News

Jounce Therapeutics News

Aktie
WKN:  A2DKZ0 ISIN:  US4811161011 US-Symbol:  JNCE
Keine aktuellen Kursdaten verfügbar
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
51,69 Mio.
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-
*Stand: 28.11.2022

Jounce Therapeutics News

03.04.23 - DGAP
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc 03-Apr-2023 / 12:25 GMT/BST FORM 8.3 PUBLIC OPENING POSITION ...
30.03.23 - DGAP
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc 30-March-2023 / 13:21 GMT/BST FORM 8.3 PUBLIC OPENING POSITION ...
29.03.23 - DGAP
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc 29-March-2023 / 13:22 GMT/BST FORM 8.3 PUBLIC OPENING POSITION ...
28.03.23 - DGAP
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc 28-March-2023 / 13:33 GMT/BST FORM 8.3 PUBLIC OPENING POSITION ...
28.03.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVT, USX, JNCE
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVT, USX, JNCE PR Newswire
27.03.23 - DGAP
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc 27-March-2023 / 13:18 GMT/BST FORM 8.3 PUBLIC OPENING POSITION ...
24.03.23 - DGAP
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc 24-March-2023 / 12:15 GMT/BST FORM 8.3 PUBLIC OPENING POSITION ...
24.03.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGEN, MNTV, JNCE
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGEN, MNTV, JNCE PR Newswire
23.03.23 - PR Newswire
Moore Kuehn Encourages JNCE, USX, INDT, and BHWB Investors to Contact Law Firm
Moore Kuehn Encourages JNCE, USX, INDT, and BHWB Investors to Contact Law Firm PR Newswire
23.03.23 - DGAP
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc 23-March-2023 / 11:09 GMT/BST FORM 8.3 PUBLIC OPENING POSITION ...
22.03.23 - DGAP
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc 22-March-2023 / 10:51 GMT/BST FORM 8.3 PUBLIC OPENING POSITION ...
21.03.23 - DGAP
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc 21-March-2023 / 10:51 GMT/BST FORM 8.3 PUBLIC OPENING POSITION ...
20.03.23 - DGAP
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc 20-March-2023 / 10:47 GMT/BST FORM 8.3 PUBLIC OPENING POSITION ...
17.03.23 - DGAP
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc 17-March-2023 / 12:07 GMT/BST FORM 8.3 PUBLIC OPENING POSITION ...
16.03.23 - DGAP
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc 16-March-2023 / 11:54 GMT/BST FORM 8.3 PUBLIC OPENING POSITION ...
15.03.23 - DGAP
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc 15-March-2023 / 11:59 GMT/BST FORM 8.3 PUBLIC OPENING POSITION ...
15.03.23 - PR Newswire
Thinking about buying stock in Jounce Therapeutics, Kingsoft Cloud, Smartsheet, Oatly Group, or Deciphera Pharmaceuticals?
Thinking about buying stock in Jounce Therapeutics, Kingsoft Cloud, Smartsheet, Oatly Group, or Deciphera Pharmaceuticals? PR Newswire
14.03.23 - DGAP
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc 14-March-2023 / 11:58 GMT/BST FORM 8.3 PUBLIC OPENING POSITION ...
10.03.23 - DGAP
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics, Inc.
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics, Inc. 10-March-2023 / 13:20 GMT/BST FORM 8.3 PUBLIC OPENING POSITION ...
07.03.23 - PR Newswire
INVESTIGATION ALERT: Halper Sadeh LLC Investigates INDT, FOCS, JNCE, PTRS
INVESTIGATION ALERT: Halper Sadeh LLC Investigates INDT, FOCS, JNCE, PTRS PR Newswire

Newssuche

Videos

newspaper
13.06.24 -3,86%
Technical Trading: Zukauf-​Chance bei Top-Trade, wenn
Sugar No.11 Long Typ: Turbo Open End WKN: VV50DP Hebel: 5 Laufzeit: OpenEnd Einstieg: prozyklisch ... Mehr »